Cover Image
市場調查報告書

冠狀動脈疾病 (CAD):全球臨床實驗檢討

Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 240579
出版日期 內容資訊 英文 100 Pages
訂單完成後即時交付
價格
Back to Top
冠狀動脈疾病 (CAD):全球臨床實驗檢討 Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2014
出版日期: 2014年08月30日 內容資訊: 英文 100 Pages
簡介

本報告提供全球冠狀動脈疾病 (CAD)治療藥物臨床實驗相關調查,不同地區的臨床實驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗資料,中斷(暫時停止,廢止,停止)的實驗清單等資料,為您概述為以下內容。

目錄

  • 表格一覽
  • 圖表一覽
  • 簡介
  • 冠狀動脈疾病 (CAD)
  • 報告指南
  • 臨床實驗 , 各地區
  • 臨床實驗 , 各國
  • - 亞太地區對臨床實驗有所貢獻的主要5個國家
  • - 歐洲對臨床實驗有所貢獻的主要5個國家
  • 對臨床實驗有所貢獻的主要國家 - 北美
  • - 中東及非洲對臨床實驗有所貢獻的主要5個國家
  • - 中南美對臨床實驗有所貢獻的主要5個國家
  • 臨床實驗 金磚四國 各國
  • 臨床實驗 G7 各國
  • 臨床實驗 - G7 各國 , 各臨床實驗狀態
  • 臨床實驗 E7 各國
  • 臨床實驗 - E7 各國 , 各臨床實驗狀態
  • 各階段臨床實驗
  • 進行中的臨床實驗 各階段
  • 臨床實驗 , 各臨床實驗狀態
  • 未完成的臨床實驗; 冠狀動脈疾病 (CAD)
  • 每段時期的實驗人數
  • 有力的贊助商
  • 參加主要企業 - 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗
  • 潛力治療藥物比較
  • 臨床實驗簡介
  • 臨床實驗概要; 主要企業
  • Abbott Laboratories
  • 臨床實驗概要; Abbott Laboratories
  • Boston Scientific Corporation
  • 臨床實驗概要; Boston Scientific Corporation
  • Cordis Corporation
  • 臨床實驗概要; Cordis Corporation
  • Medtronic, Inc.
  • 臨床實驗概要; Medtronic, Inc.
  • Johnson & Johnson
  • 臨床實驗概要; Johnson & Johnson
  • AstraZeneca PLC
  • 臨床實驗概要; AstraZeneca PLC
  • GE Healthcare
  • 臨床實驗概要; GE Healthcare
  • Pfizer Inc.
  • 臨床實驗概要; Pfizer Inc.
  • Gilead Sciences, Inc.
  • 臨床實驗概要; Gilead Sciences, Inc.
  • Eli Lilly and Company
  • 臨床實驗概要; Eli Lilly and Company
  • POINT Biomedical Corporation
  • 臨床實驗概要; POINT Biomedical Corporation
  • Sahajanand Medical Technologies Pvt. Ltd.
  • 臨床實驗概要; Sahajanand Medical Technologies Pvt. Ltd.
  • Lantheus Medical Imaging, Inc.
  • 臨床實驗概要; Lantheus Medical Imaging, Inc.
  • Astellas
  • 臨床實驗概要; Astellas
  • Cook
  • 臨床實驗概要; Cook
  • Bracco Diagnostics, Inc.
  • 臨床實驗概要; Bracco Diagnostics, Inc.
  • Sanofi
  • 臨床實驗概要; Sanofi
  • Intermountain Healthcare, Inc.
  • 臨床實驗概要; Intermountain Healthcare, Inc.
  • Forest Laboratories, Inc.
  • 臨床實驗概要; Forest Laboratories, Inc.
  • 小野藥品工業
  • 臨床實驗概要; 小野藥品工業
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • Seoul National University Hospital
  • 臨床實驗概要; Seoul National University Hospital
  • Sapienza University of Rome
  • 臨床實驗概要; Sapienza University of Rome
  • University of Ottawa Heart Institute
  • 臨床實驗概要; University of Ottawa Heart Institute
  • Yonsei University
  • 臨床實驗概要; Yonsei University
  • 熊本大學
  • 臨床實驗概要; 熊本大學
  • Emory University
  • 臨床實驗概要; Emory University
  • University Hospital Inselspital, Berne
  • 臨床實驗概要; University Hospital Inselspital, Berne
  • Norwegian University of Science and Technology
  • 臨床實驗概要; Norwegian University of Science and Technology
  • National Taiwan University Hospital
  • 臨床實驗概要; National Taiwan University Hospital
  • MedStar Health Research Institute
  • 臨床實驗概要; MedStar Health Research Institute
  • 京都大學
  • 臨床實驗概要; 京都大學
  • Samsung Medical Center
  • 臨床實驗概要; Samsung Medical Center
  • University of Sao Paulo
  • 臨床實驗概要; University of Sao Paulo
  • Deutsches Herzzentrum Munchen
  • 臨床實驗概要; Deutsches Herzzentrum Munchen
  • Mayo Clinic
  • 臨床實驗概要; Mayo Clinic
  • Oslo University Hospital
  • 臨床實驗概要; Oslo University Hospital
  • University of Leipzig
  • 臨床實驗概要; University of Leipzig
  • Massachusetts General Hospital
  • 臨床實驗概要; Massachusetts General Hospital
  • Skejby Hospital
  • 臨床實驗概要; Skejby Hospital
  • Montreal Heart Institute Research Centre
  • 臨床實驗概要; Montreal Heart Institute Research Centre
  • Five 主要 臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • About GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

表格一覽

  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 臨床實驗 各地區
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 臨床實驗 , 各國排名
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 進行中的臨床實驗 , 各國排名
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 亞太地區, 主要5個國家
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 歐洲, 主要5個國家
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 北美, 主要國家
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 中東及非洲, 主要5個國家
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 中南美, 主要5個國家
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 金磚四國 各國
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, G7 各國
  • 冠狀動脈疾病 (CAD) 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, E7 各國
  • 冠狀動脈疾病 (CAD) 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 各階段臨床實驗
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 進行中的臨床實驗 各階段
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 臨床實驗 , 各臨床實驗狀態
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 暫時停止的臨床實驗
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 中止的臨床實驗
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 終止的臨床實驗
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 全球市場、 平均登計對象人數趨勢
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 全球市場、 主要的贊助商
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 全球市場、 主要企業 各階段
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 全球市場、 臨床實驗, 各有潛力治療藥
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Abbott Laboratories
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Boston Scientific Corporation
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Cordis Corporation
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Medtronic, Inc.
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Johnson & Johnson
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- AstraZeneca PLC
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- GE Healthcare
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Pfizer Inc.
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Gilead Sciences, Inc.
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Eli Lilly and Company
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- POINT Biomedical Corporation
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Sahajanand Medical Technologies Pvt. Ltd.
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Lantheus Medical Imaging, Inc.
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Astellas
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Cook
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Bracco Diagnostics, Inc.
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Sanofi
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Intermountain Healthcare, Inc.
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Forest Laboratories, Inc.
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- 小野藥品工業
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Seoul National University Hospital
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Sapienza University of Rome
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- University of Ottawa Heart Institute
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Yonsei University
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- 熊本大學
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Emory University
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- University Hospital Inselspital, Berne
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Norwegian University of Science and Technology
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- National Taiwan University Hospital
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- MedStar Health Research Institute
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- 京都大學
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Samsung Medical Center
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- University of Sao Paulo
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Deutsches Herzzentrum Munchen
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Mayo Clinic
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Oslo University Hospital
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- University of Leipzig
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Massachusetts General Hospital
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Skejby Hospital
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Montreal Heart Institute Research Centre

圖表一覽

圖表一覽

  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 臨床實驗 各地區 (%)
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 臨床實驗 , 各國排名
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 進行中的臨床實驗 , 各國排名
  • (%)冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 亞太地區, 主要5個國家
  • (%)冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 歐洲, 主要5個國家
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 北美, 主要國家 (%)
  • (%)冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 中東及非洲, 主要5個國家
  • (%)冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 中南美, 主要5個國家
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 金磚四國 各國 (%)
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, G7 各國 (%)
  • 冠狀動脈疾病 (CAD) 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, E7 各國 (%)
  • 冠狀動脈疾病 (CAD) 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 各階段臨床實驗 (%)
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 進行中的臨床實驗 各階段
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 臨床實驗 , 各臨床實驗狀態
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 全球市場、 平均登計對象人數趨勢
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 全球市場、 主要的贊助商
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 全球市場、 主要企業 各階段
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 全球市場、 臨床實驗, 各有潛力治療藥
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2014" provides data on the Coronary Artery Disease (CAD) (Ischemic Heart Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Artery Disease (CAD) (Ischemic Heart Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Artery Disease (CAD) (Ischemic Heart Disease). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Coronary Artery Disease (CAD) (Ischemic Heart Disease)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Coronary Artery Disease (CAD) (Ischemic Heart Disease)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • Medtronic, Inc.
      • Clinical Trial Overview of Medtronic, Inc.
      • Boston Scientific Corporation
      • Clinical Trial Overview of Boston Scientific Corporation
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • Yonsei University
      • Clinical Trial Overview of Yonsei University
      • Cardiovascular Research Foundation
      • Clinical Trial Overview of Cardiovascular Research Foundation
      • Kumamoto University
      • Clinical Trial Overview of Kumamoto University
      • University of Florida
      • Clinical Trial Overview of University of Florida
      • Tehran University of Medical Sciences
      • Clinical Trial Overview of Tehran University of Medical Sciences
      • Emory University
      • Clinical Trial Overview of Emory University
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Kyoto University
      • Clinical Trial Overview of Kyoto University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic, Inc., 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Scientific Corporation, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiovascular Research Foundation, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2014*

List of Figures

  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top